05 Sep 23
Meet o2h discovery’s Medicinal Chemistry team at booth 18, at the SCI-RSC 22nd Medicinal Chemistry Symposium
We are excited to be participating in the SCI-RSC 22nd Medicinal Chemistry Symposium scheduled from 10-13 September, 2023 at Churchill College, Cambridge, UK.
Medicinal chemistry plays a crucial role in today’s healthcare landscape by serving as the bridge between chemistry and medicine, facilitating the design and development of pharmaceutical compounds that target specific diseases and conditions. This interdisciplinary field combines chemistry, biology, and pharmacology to optimize molecules for precise biological targets, often leveraging computational techniques for efficiency.
Its ongoing innovation remains essential in addressing ever-evolving medical challenges and improving the quality of life for patients and individuals in need.
At o2h discovery, we believe in collaboration in drug discovery and have been building a global community of medicinal chemists between Cambridge UK and Cambridge, Boston, Massachusetts. Our diverse scientific and medicinal team, including Andy Morley, Chief Scientific Officer, and David Davies, Head of Medicinal Chemistry, carry decades of experience, collaborating on groundbreaking research projects in different life-science and disease areas that have an impact on human health.
SCI-RSC 22nd Medicinal Chemistry Symposium is Europe’s premier biennial Medicinal Chemistry event, aimed at focusing on diverse topics, including pre-clinical and clinical evolution in the medical world, the introduction of AI-based drug discovery, and more. Read more.
Feel free to contact Claudio Dagostin, Vice President, Business Development, UK, and Simon Stockwell, Senior Scientist at o2h discovery (UK Biology Team) to discuss our expertise in drug discovery and medicinal chemistry solutions.
About o2h discovery:
o2h discovery is a Contract Research Organization that has an integrated drug discovery platform operating from our state-of-the-art research centers in Ahmedabad, India and The Mill SciTech Park, Cambridge, UK.
We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development. To know more about o2h discovery, visit – https://o2h.com/discovery/chemistry/
Our drug discovery research service offerings include:
To book a meeting, please write us at discovery@o2h.com
For more information, visit o2h.com or contact us at: https://o2h.com/contact/
